Literature DB >> 10973734

Apoptotic photoreceptor death in the rhodopsin knockout mouse in the presence and absence of c-fos.

A H Hobson1, M Donovan, M M Humphries, G Tuohy, N McNally, R Carmody, T Cotter, G J Farrar, P F Kenna, P Humphries.   

Abstract

A combined total of approximately 100 mutations have been encountered within the rhodopsin gene in retinitis pigmentosa (RP) and congenital night blindness. Mice carrying a targeted disruption of the rhodopsin gene phenotypically mimic RP, losing their photoreceptors over a period of 3 months and having no recordable rod electroretinogram. These animals will serve as a model for both recessive and dominant disease (in the latter case, the presence of normal and mutant human rod opsin transgenes on the murine Rho(-/-)background). Precise knowledge of apoptotic photoreceptor cell death, together with factors which may influence apoptosis will be required for optimum utility of Rho(-/-)mice as a model for therapeutic genetic intervention. A peak phase of apoptosis of the photoreceptors of Rho(-/-)mice was shown to occur at 24 days post-birth. The extent of apoptosis appeared to be similar, irrespective of whether or not the rod opsin knockout was present on a c-fos(+/+)or c-fos(-/-)genetic background, the latter known to favor survival of photoreceptors following exposure of mouse retinas to excessive light. These data clearly support the existence in animals of distinct apoptotic pathways in light-induced, as opposed to mutation-induced apoptosis, and together with similar observations recently reported in studies of the naturally occurring rd mouse, may assist in focusing future research on precisely defining the distinct molecular pathways giving rise to such dichotomy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973734     DOI: 10.1006/exer.2000.0878

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Gene transcription profile of the detached retina (An AOS Thesis).

Authors:  David N Zacks
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

2.  Bone spicule pigment formation in retinitis pigmentosa: insights from a mouse model.

Authors:  Gesine B Jaissle; Christian Albrecht May; Serge A van de Pavert; Andreas Wenzel; Ellen Claes-May; Andreas Giessl; Peter Szurman; Uwe Wolfrum; Jan Wijnholds; M D Fischer; M D Fisher; P Humphries; M W Seeliger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

3.  Sustained delivery of NT-3 from lens fiber cells in transgenic mice reveals specificity of neuroprotection in retinal degenerations.

Authors:  Matthew M Lavail; Shimpei Nishikawa; Jacque L Duncan; Haidong Yang; Michael T Matthes; Douglas Yasumura; Douglas Vollrath; Paul A Overbeek; John D Ash; Michael L Robinson
Journal:  J Comp Neurol       Date:  2008-12-20       Impact factor: 3.215

4.  CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.

Authors:  Daniel M Lipinski; Alun R Barnard; Mandeep S Singh; Chris Martin; Edward J Lee; Wayne I L Davies; Robert E MacLaren
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

5.  ADIPOR1 deficiency-induced suppression of retinal ELOVL2 and docosahexaenoic acid levels during photoreceptor degeneration and visual loss.

Authors:  Hideto Osada; Eriko Toda; Kohei Homma; Naymel A Guzman; Norihiro Nagai; Mamoru Ogawa; Kazuno Negishi; Makoto Arita; Kazuo Tsubota; Yoko Ozawa
Journal:  Cell Death Dis       Date:  2021-05-07       Impact factor: 8.469

6.  Absence of ephrin-A2/A3 increases retinal regenerative potential for Müller cells in Rhodopsin knockout mice.

Authors:  Rui-Lin Zhu; Yuan Fang; Hong-Hua Yu; Dong F Chen; Liu Yang; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 7.  Targeting Neurovascular Interaction in Retinal Disorders.

Authors:  Zhongjie Fu; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Zhongxiao Wang; Chi-Hsiu Liu; Steve S Cho; William Britton; Timothy S Kern; David A Antonetti; Ann Hellström; Lois E H Smith
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

Review 8.  Targeting Neuroinflammation in Neovascular Retinal Diseases.

Authors:  Tianxi Wang; Demetrios I Tsirukis; Ye Sun
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.